TERN-501
- Generic Name
- TERN-501
DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis
Phase 2
Completed
- Conditions
- NASH - Nonalcoholic Steatohepatitis
- Interventions
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Terns, Inc.
- Target Recruit Count
- 162
- Registration Number
- NCT05415722
- Locations
- 🇺🇸
Site 1003: Clinical Trials of Texas, LLC, San Antonio, Texas, United States
🇺🇸Site 1006: American Research Corporation, San Antonio, Texas, United States
🇺🇸Site 1053 Bon Secours Richmond Community Hospital LLC d/b/a Bon Secours Liver Institute of Richmond, Richmond, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath